On March 5, 2026, VistaGen Therapeutics, Inc. implemented a Board-approved reduction in its workforce by approximately 20%. This action was disclosed in an 8-K filing on March 11, 2026, under Item 8.01 Other Events.
Key takeaways
Workforce reduced by approximately 20% on March 5, 2026